Type |
Details |
Score |
Publication |
First Author: |
Miallot R |
Year: |
2023 |
Journal: |
Life Sci Alliance |
Title: |
An OMA1 redox site controls mitochondrial homeostasis, sarcoma growth, and immunogenicity. |
Volume: |
6 |
Issue: |
6 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Yamazaki C |
Year: |
2013 |
Journal: |
J Immunol |
Title: |
Critical roles of a dendritic cell subset expressing a chemokine receptor, XCR1. |
Volume: |
190 |
Issue: |
12 |
Pages: |
6071-82 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shimizu K |
Year: |
2013 |
Journal: |
J Immunol |
Title: |
Invariant NKT cells induce plasmacytoid dendritic cell (DC) cross-talk with conventional DCs for efficient memory CD8+ T cell induction. |
Volume: |
190 |
Issue: |
11 |
Pages: |
5609-19 |
|
•
•
•
•
•
|
Publication |
First Author: |
Devi S |
Year: |
2021 |
Journal: |
Immunity |
Title: |
Adrenergic regulation of the vasculature impairs leukocyte interstitial migration and suppresses immune responses. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Roberts EW |
Year: |
2016 |
Journal: |
Cancer Cell |
Title: |
Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma. |
Volume: |
30 |
Issue: |
2 |
Pages: |
324-336 |
|
•
•
•
•
•
|
Publication |
First Author: |
Salei N |
Year: |
2021 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Selective depletion of a CD64-expressing phagocyte subset mediates protection against toxic kidney injury and failure. |
Volume: |
118 |
Issue: |
39 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Xiao H |
Year: |
2024 |
Journal: |
Nat Commun |
Title: |
Genomic deletion of Bcl6 differentially affects conventional dendritic cell subsets and compromises Tfh/Tfr/Th17 cell responses. |
Volume: |
15 |
Issue: |
1 |
Pages: |
3554 |
|
•
•
•
•
•
|
Publication |
First Author: |
Salomon R |
Year: |
2022 |
Journal: |
Nat Cancer |
Title: |
Bispecific antibodies increase the therapeutic window of CD40 agonists through selective dendritic cell targeting. |
Volume: |
3 |
Issue: |
3 |
Pages: |
287-302 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dimonte S |
Year: |
2021 |
Journal: |
Immunology |
Title: |
Optimal CD8+ T-cell memory formation following subcutaneous cytomegalovirus infection requires virus replication but not early dendritic cell responses. |
Volume: |
164 |
Issue: |
2 |
Pages: |
279-291 |
|
•
•
•
•
•
|
Publication |
First Author: |
Deczkowska A |
Year: |
2021 |
Journal: |
Nat Med |
Title: |
XCR1(+) type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis. |
Volume: |
27 |
Issue: |
6 |
Pages: |
1043-1054 |
|
•
•
•
•
•
|
Publication |
First Author: |
Brabec T |
Year: |
2024 |
Journal: |
J Exp Med |
Title: |
Segmented filamentous bacteria-induced epithelial MHCII regulates cognate CD4+ IELs and epithelial turnover. |
Volume: |
221 |
Issue: |
1 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Barry KC |
Year: |
2018 |
Journal: |
Nat Med |
Title: |
A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments. |
Volume: |
24 |
Issue: |
8 |
Pages: |
1178-1191 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lança T |
Year: |
2022 |
Journal: |
Immunity |
Title: |
IRF8 deficiency induces the transcriptional, functional, and epigenetic reprogramming of cDC1 into the cDC2 lineage. |
Volume: |
55 |
Issue: |
8 |
Pages: |
1431-1447.e11 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhou T |
Year: |
2020 |
Journal: |
Nature |
Title: |
IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy. |
Volume: |
583 |
Issue: |
7817 |
Pages: |
609-614 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ugur M |
Year: |
2023 |
Journal: |
Immunity |
Title: |
Lymph node medulla regulates the spatiotemporal unfolding of resident dendritic cell networks. |
Volume: |
56 |
Issue: |
8 |
Pages: |
1778-1793.e10 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yamasaki S |
Year: |
2016 |
Journal: |
Sci Rep |
Title: |
In vivo dendritic cell targeting cellular vaccine induces CD4+ Tfh cell-dependent antibody against influenza virus. |
Volume: |
6 |
|
Pages: |
35173 |
|
•
•
•
•
•
|
Publication |
First Author: |
Daniels NJ |
Year: |
2016 |
Journal: |
Mucosal Immunol |
Title: |
Antigen-specific cytotoxic T lymphocytes target airway CD103+ and CD11b+ dendritic cells to suppress allergic inflammation. |
Volume: |
9 |
Issue: |
1 |
Pages: |
229-39 |
|
•
•
•
•
•
|
Publication |
First Author: |
De Giovanni M |
Year: |
2020 |
Journal: |
Nat Immunol |
Title: |
Spatiotemporal regulation of type I interferon expression determines the antiviral polarization of CD4+ T cells. |
Volume: |
21 |
Issue: |
3 |
Pages: |
321-330 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ruhland MK |
Year: |
2020 |
Journal: |
Cancer Cell |
Title: |
Visualizing Synaptic Transfer of Tumor Antigens among Dendritic Cells. |
Volume: |
37 |
Issue: |
6 |
Pages: |
786-799.e5 |
|
•
•
•
•
•
|
Publication |
First Author: |
Muleta KG |
Year: |
2022 |
Journal: |
Front Immunol |
Title: |
Rotavirus-Induced Expansion of Antigen-Specific CD8 T Cells Does Not Require Signaling via TLR3, MyD88 or the Type I Interferon Receptor. |
Volume: |
13 |
|
Pages: |
814491 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dähling S |
Year: |
2022 |
Journal: |
Immunity |
Title: |
Type 1 conventional dendritic cells maintain and guide the differentiation of precursors of exhausted T cells in distinct cellular niches. |
Volume: |
55 |
Issue: |
4 |
Pages: |
656-670.e8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mahadevan KK |
Year: |
2024 |
Journal: |
Science |
Title: |
Type I conventional dendritic cells facilitate immunotherapy in pancreatic cancer. |
Volume: |
384 |
Issue: |
6703 |
Pages: |
eadh4567 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dahlgren MW |
Year: |
2022 |
Journal: |
Front Immunol |
Title: |
Type I Interferons Promote Germinal Centers Through B Cell Intrinsic Signaling and Dendritic Cell Dependent Th1 and Tfh Cell Lineages. |
Volume: |
13 |
|
Pages: |
932388 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ahmadi F |
Year: |
2023 |
Journal: |
J Exp Med |
Title: |
cDC1-derived IL-27 regulates small intestinal CD4+ T cell homeostasis in mice. |
Volume: |
220 |
Issue: |
3 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Hildreth AD |
Year: |
2023 |
Journal: |
Cell Rep |
Title: |
Sterile liver injury induces a protective tissue-resident cDC1-ILC1 circuit through cDC1-intrinsic cGAS-STING-dependent IL-12 production. |
Volume: |
42 |
Issue: |
2 |
Pages: |
112141 |
|
•
•
•
•
•
|
Publication |
First Author: |
Guo C |
Year: |
2023 |
Journal: |
Nature |
Title: |
SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity. |
Volume: |
620 |
Issue: |
7972 |
Pages: |
200-208 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tsuchiya N |
Year: |
2019 |
Journal: |
Cell Rep |
Title: |
Type I Interferon Delivery by iPSC-Derived Myeloid Cells Elicits Antitumor Immunity via XCR1+ Dendritic Cells. |
Volume: |
29 |
Issue: |
1 |
Pages: |
162-175.e9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mitchell JS |
Year: |
2024 |
Journal: |
Immunity |
Title: |
CD4(+) T cells reactive to a hybrid peptide from insulin-chromogranin A adopt a distinct effector fate and are pathogenic in autoimmune diabetes. |
Volume: |
57 |
Issue: |
10 |
Pages: |
2399-2415.e8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Flommersfeld S |
Year: |
2021 |
Journal: |
Immunity |
Title: |
Fate mapping of single NK cells identifies a type 1 innate lymphoid-like lineage that bridges innate and adaptive recognition of viral infection. |
Volume: |
54 |
Issue: |
10 |
Pages: |
2288-2304.e7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Diener N |
Year: |
2021 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Posttranslational modifications by ADAM10 shape myeloid antigen-presenting cell homeostasis in the splenic marginal zone. |
Volume: |
118 |
Issue: |
38 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Wu R |
Year: |
2022 |
Journal: |
Nat Immunol |
Title: |
Mechanisms of CD40-dependent cDC1 licensing beyond costimulation. |
Volume: |
23 |
Issue: |
11 |
Pages: |
1536-1550 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ferris ST |
Year: |
2020 |
Journal: |
Nature |
Title: |
cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity. |
Volume: |
584 |
Issue: |
7822 |
Pages: |
624-629 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gargaro M |
Year: |
2022 |
Journal: |
Immunity |
Title: |
Indoleamine 2,3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communication. |
Volume: |
55 |
Issue: |
6 |
Pages: |
1032-1050.e14 |
|
•
•
•
•
•
|
Publication |
First Author: |
Christian DA |
Year: |
2022 |
Journal: |
Sci Immunol |
Title: |
cDC1 coordinate innate and adaptive responses in the omentum required for T cell priming and memory. |
Volume: |
7 |
Issue: |
75 |
Pages: |
eabq7432 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zagorulya M |
Year: |
2023 |
Journal: |
Immunity |
Title: |
Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer. |
Volume: |
56 |
Issue: |
2 |
Pages: |
386-405.e10 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fernandez-Ruiz D |
Year: |
2017 |
Journal: |
J Immunol |
Title: |
Development of a Novel CD4+ TCR Transgenic Line That Reveals a Dominant Role for CD8+ Dendritic Cells and CD40 Signaling in the Generation of Helper and CTL Responses to Blood-Stage Malaria. |
Volume: |
199 |
Issue: |
12 |
Pages: |
4165-4179 |
|
•
•
•
•
•
|
Publication |
First Author: |
de Mingo Pulido Á |
Year: |
2021 |
Journal: |
Immunity |
Title: |
The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake. |
Volume: |
54 |
Issue: |
6 |
Pages: |
1154-1167.e7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kumar SRP |
Year: |
2024 |
Journal: |
Mol Ther |
Title: |
TLR9-independent CD8(+) T cell responses in hepatic AAV gene transfer through IL-1R1-MyD88 signaling. |
Volume: |
32 |
Issue: |
2 |
Pages: |
325-339 |
|
•
•
•
•
•
|
Publication |
First Author: |
Meiser P |
Year: |
2023 |
Journal: |
Cancer Cell |
Title: |
A distinct stimulatory cDC1 subpopulation amplifies CD8(+) T cell responses in tumors for protective anti-cancer immunity. |
Volume: |
41 |
Issue: |
8 |
Pages: |
1498-1515.e10 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gopinath S |
Year: |
2018 |
Journal: |
Nat Microbiol |
Title: |
Topical application of aminoglycoside antibiotics enhances host resistance to viral infections in a microbiota-independent manner. |
Volume: |
3 |
Issue: |
5 |
Pages: |
611-621 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kiss H |
Year: |
2002 |
Journal: |
Mamm Genome |
Title: |
Comparative human/murine sequence analysis of the common eliminated region 1 from human 3p21.3. |
Volume: |
13 |
Issue: |
11 |
Pages: |
646-55 |
|
•
•
•
•
•
|
Publication |
First Author: |
Williams JW |
Year: |
2020 |
Journal: |
Nat Immunol |
Title: |
Limited proliferation capacity of aortic intima resident macrophages requires monocyte recruitment for atherosclerotic plaque progression. |
Volume: |
21 |
Issue: |
10 |
Pages: |
1194-1204 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tanoue T |
Year: |
2019 |
Journal: |
Nature |
Title: |
A defined commensal consortium elicits CD8 T cells and anti-cancer immunity. |
Volume: |
565 |
Issue: |
7741 |
Pages: |
600-605 |
|
•
•
•
•
•
|
Publication |
First Author: |
Deltagen Inc |
Year: |
2005 |
Journal: |
MGI Direct Data Submission |
Title: |
NIH initiative supporting placement of Deltagen, Inc. mice into public repositories |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Shanghai Model Organisms Center |
Year: |
2017 |
Journal: |
MGI Direct Data Submission |
Title: |
Information obtained from the Shanghai Model Organisms Center (SMOC), Shanghai, China |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
The RIKEN BioResource Center |
Year: |
2006 |
Journal: |
Unpublished |
Title: |
Information obtained from The RIKEN BioResource Center |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
NIH Mouse Knockout Inventory |
Year: |
2004 |
Journal: |
MGI Direct Data Submission |
Title: |
Information obtained from the NIH Mouse Knockout Inventory |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2005 |
|
Title: |
Mouse Synonym Curation |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
The Gene Ontology Consortium |
Year: |
2016 |
|
Title: |
Automatic assignment of GO terms using logical inference, based on on inter-ontology links |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
GUDMAP Consortium |
Year: |
2004 |
Journal: |
www.gudmap.org |
Title: |
GUDMAP: the GenitoUrinary Development Molecular Anatomy Project |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
UniProt-GOA |
Year: |
2012 |
|
Title: |
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
DDB, FB, MGI, GOA, ZFIN curators |
Year: |
2001 |
|
Title: |
Gene Ontology annotation through association of InterPro records with GO terms |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Magdaleno S |
Year: |
2006 |
Journal: |
PLoS Biol |
Title: |
BGEM: an in situ hybridization database of gene expression in the embryonic and adult mouse nervous system. |
Volume: |
4 |
Issue: |
4 |
Pages: |
e86 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2002 |
|
Title: |
Chromosome assignment of mouse genes using the Mouse Genome Sequencing Consortium (MGSC) assembly and the ENSEMBL Database |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
MGD Nomenclature Committee |
Year: |
1995 |
|
Title: |
Nomenclature Committee Use |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
GemPharmatech |
Year: |
2020 |
|
Title: |
GemPharmatech Website. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Cyagen Biosciences Inc. |
Year: |
2022 |
|
Title: |
Cyagen Biosciences Website. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Okazaki Y |
Year: |
2002 |
Journal: |
Nature |
Title: |
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. |
Volume: |
420 |
Issue: |
6915 |
Pages: |
563-73 |
|
•
•
•
•
•
|
Publication |
First Author: |
Diez-Roux G |
Year: |
2011 |
Journal: |
PLoS Biol |
Title: |
A high-resolution anatomical atlas of the transcriptome in the mouse embryo. |
Volume: |
9 |
Issue: |
1 |
Pages: |
e1000582 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2010 |
Journal: |
Database Download |
Title: |
Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Genome U74 Array Platform (A, B, C v2). |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
MGI Genome Annotation Group and UniGene Staff |
Year: |
2015 |
Journal: |
Database Download |
Title: |
MGI-UniGene Interconnection Effort |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Marc Feuermann, Huaiyu Mi, Pascale Gaudet, Dustin Ebert, Anushya Muruganujan, Paul Thomas |
Year: |
2010 |
|
Title: |
Annotation inferences using phylogenetic trees |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Database and National Center for Biotechnology Information |
Year: |
2000 |
Journal: |
Database Release |
Title: |
Entrez Gene Load |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Allen Institute for Brain Science |
Year: |
2004 |
Journal: |
Allen Institute |
Title: |
Allen Brain Atlas: mouse riboprobes |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2009 |
Journal: |
Database Download |
Title: |
Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Gene 1.0 ST Array Platform |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics (MGI) and The National Center for Biotechnology Information (NCBI) |
Year: |
2010 |
Journal: |
Database Download |
Title: |
Consensus CDS project |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Group |
Year: |
2003 |
Journal: |
Database Procedure |
Title: |
Automatic Encodes (AutoE) Reference |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Bairoch A |
Year: |
1999 |
Journal: |
Database Release |
Title: |
SWISS-PROT Annotated protein sequence database |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2005 |
|
Title: |
Obtaining and Loading Genome Assembly Coordinates from Ensembl Annotations |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics |
Year: |
2010 |
Journal: |
Database Release |
Title: |
Protein Ontology Association Load. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2005 |
|
Title: |
Obtaining and loading genome assembly coordinates from NCBI annotations |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2009 |
Journal: |
Database Download |
Title: |
Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Genome 430 2.0 Array Platform |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Huang H |
Year: |
2001 |
Journal: |
Biochem Biophys Res Commun |
Title: |
Neutrophils and B cells express XCR1 receptor and chemotactically respond to lymphotactin. |
Volume: |
281 |
Issue: |
2 |
Pages: |
378-82 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lei Y |
Year: |
2012 |
Journal: |
Microbes Infect |
Title: |
XCL1 and XCR1 in the immune system. |
Volume: |
14 |
Issue: |
3 |
Pages: |
262-7 |
|
•
•
•
•
•
|
Allele |
Name: |
chemokine (C motif) receptor 1; endonuclease-mediated mutation 1, Shanghai Model Organisms Center |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Recombinase |
|
•
•
•
•
•
|
Publication |
First Author: |
Xu F |
Year: |
2019 |
Journal: |
Dev Comp Immunol |
Title: |
Genetic diversity of chemokine XCL1 and its receptor XCR1 in murine rodents. |
Volume: |
98 |
|
Pages: |
80-88 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
Allele |
Name: |
chemokine (C motif) receptor 1; targeted mutation 1, Centre d'ImmunoPhenomique |
Allele Type: |
Targeted |
Attribute String: |
Recombinase |
|
•
•
•
•
•
|
Publication |
First Author: |
Lei Y |
Year: |
2011 |
Journal: |
J Exp Med |
Title: |
Aire-dependent production of XCL1 mediates medullary accumulation of thymic dendritic cells and contributes to regulatory T cell development. |
Volume: |
208 |
Issue: |
2 |
Pages: |
383-94 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yoshida T |
Year: |
1998 |
Journal: |
J Biol Chem |
Title: |
Identification of single C motif-1/lymphotactin receptor XCR1. |
Volume: |
273 |
Issue: |
26 |
Pages: |
16551-4 |
|
•
•
•
•
•
|
HT Experiment |
|
Experiment Type: |
RNA-Seq |
Study Type: |
Baseline |
Source: |
GEO |
|
•
•
•
•
•
|
Publication |
First Author: |
Bagadia P |
Year: |
2021 |
Journal: |
J Immunol |
Title: |
Bcl6-Independent In Vivo Development of Functional Type 1 Classical Dendritic Cells Supporting Tumor Rejection. |
Volume: |
207 |
Issue: |
1 |
Pages: |
125-132 |
|
•
•
•
•
•
|
Publication |
First Author: |
Calabro S |
Year: |
2016 |
Journal: |
Cell Rep |
Title: |
Differential Intrasplenic Migration of Dendritic Cell Subsets Tailors Adaptive Immunity. |
Volume: |
16 |
Issue: |
9 |
Pages: |
2472-85 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kim TS |
Year: |
2015 |
Journal: |
J Clin Invest |
Title: |
Stress-associated erythropoiesis initiation is regulated by type 1 conventional dendritic cells. |
Volume: |
125 |
Issue: |
10 |
Pages: |
3965-80 |
|
•
•
•
•
•
|
Publication |
First Author: |
Silva-Sanchez A |
Year: |
2023 |
Journal: |
Sci Immunol |
Title: |
Activation of regulatory dendritic cells by Mertk coincides with a temporal wave of apoptosis in neonatal lungs. |
Volume: |
8 |
Issue: |
84 |
Pages: |
eadc9081 |
|
•
•
•
•
•
|
Publication |
First Author: |
Moorman CD |
Year: |
2023 |
Journal: |
Front Immunol |
Title: |
CAR-T cells and CAR-Tregs targeting conventional type-1 dendritic cell suppress experimental autoimmune encephalomyelitis. |
Volume: |
14 |
|
Pages: |
1235222 |
|
•
•
•
•
•
|
Publication |
First Author: |
Matsuo K |
Year: |
2018 |
Journal: |
Front Immunol |
Title: |
A Highly Active Form of XCL1/Lymphotactin Functions as an Effective Adjuvant to Recruit Cross-Presenting Dendritic Cells for Induction of Effector and Memory CD8+ T Cells. |
Volume: |
9 |
|
Pages: |
2775 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kelner GS |
Year: |
1994 |
Journal: |
Science |
Title: |
Lymphotactin: a cytokine that represents a new class of chemokine. |
Volume: |
266 |
Issue: |
5189 |
Pages: |
1395-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kennedy J |
Year: |
1995 |
Journal: |
J Immunol |
Title: |
Molecular cloning and functional characterization of human lymphotactin. |
Volume: |
155 |
Issue: |
1 |
Pages: |
203-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Giancarlo B |
Year: |
1996 |
Journal: |
Eur J Immunol |
Title: |
Migratory response of human natural killer cells to lymphotactin. |
Volume: |
26 |
Issue: |
12 |
Pages: |
3238-41 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Chemokines (chemotactic cytokines) are a family of chemoattractant molecules. They attract leukocytes to areas of inflammation and lesions, and play a key role in leukocyte activation. Originally defined as host defense proteins, chemokines are now known to play a much broader biological role []. They have a wide range of effects in many different cell types beyond the immune system, including, for example, various cells of the central nervous system [], and endothelial cells, where they may act as either angiogenic or angiostatic factors [].The chemokine family is divided into four classes based on the number and spacing of their conserved cysteines: 2 Cys residues may be adjacent (the CC family); separated by an intervening residue (the CXC family); have only one of the first two Cys residues (C chemokines); or contain both cysteines, separated by three intervening residues (CX3C chemokines).Chemokines exert their effects by binding to rhodopsin-like G protein-coupled receptors on the surface of cells. Following interaction with their specific chemokine ligands, chemokine receptors trigger a flux in intracellular calcium ions, which cause a cellular response, including the onset of chemotaxis. There are over fifty distinct chemokines and least 18 human chemokine receptors []. Although the receptors bind only a single class of chemokines, they often bind several members of the same class with high affinity. Chemokine receptors are preferentially expressedon important functional subsets of dendritic cells, monocytes and lymphocytes, including Langerhans cells and T helper cells [, ]. Chemokines and their receptors can also be subclassified into homeostatic leukocyte homing molecules (CXCR4, CXCR5, CCR7, CCR9) versus inflammatory/inducible molecules (CXCR1, CXCR2, CXCR3, CCR1-6, CX3CR1).Chemokine XC receptor 1 (XCR1), which this entry represents is a receptor for lymphotactin []. Lymphotactin is the only known member of the C (or XC) chemokine family, and is produced by certain subsets of T cells and natural killer cells and is also chemotactic for these cell types []. XCR1 is strongly expressed in placenta and at lower levels in the spleen and thymus and detected only at very low levels in peripheral blood leukocytes []. Within these tissues, expression is restricted to CD8+ T cells and natural killer cells [, ]. Binding of lymphotactin to XCR1 stimulates calcium mobilisation and migration in a pertussis toxin-sensitive manner, indicating coupling of the receptor to Gi type proteins [, ]. The matching expression patterns of both lymphotactin and its receptor suggest a role for the chemokine in self-recruitment of leukocytes []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Palomino DC |
Year: |
2015 |
Journal: |
Einstein (Sao Paulo) |
Title: |
Chemokines and immunity. |
Volume: |
13 |
Issue: |
3 |
Pages: |
469-73 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
The chemokine family is divided into four classes based on the number and spacing of their conserved cysteines: 2 Cys residues may be adjacent (the CC family), or separated by an intervening residue (the CXC family), or have only one of the first two Cys residues (C chemokines), or contain both cysteines separated by three intervening residues (CX3C chemokines).This entry includes beta-chemokines (CC chemokines), in addition to gamma (C chemokines) and delta-chemokines (CX3C chemokines). CC chemokines stimulate mainly monocytes, but also basophils, eosinophils, T-lymphocytes, and natural killer (NK) cells. C-C motif chemokine 2 (CCL2) stimulates chemotaxis of monocytes and several cellular events associated with chemotaxis. Two other chemokines structurally related to CCL2 are CCL8 (MCP-2) and CCL7 (MCP-3) [].The C chemokine subfamily is composed of two members, XC chemokine ligand 1 (XCL1), also known as lymphotactin or SCM-1 alpha, and XC chemokine ligand 2 (XCL2), also known as SCM-1 beta []. The cognate receptor for these chemokines is XCR1 []. The only CX3C chemokine identified to date is CX3C chemokine ligand 1 (CX3CL1), also known as fractalkine or neurotactin. With its unique CX3CR1 receptor [], it is involved in adherence to the endothelium of the inflammatory monocyte population []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Yoshida T |
Year: |
1996 |
Journal: |
FEBS Lett |
Title: |
Structure and expression of two highly related genes encoding SCM-1/human lymphotactin. |
Volume: |
395 |
Issue: |
1 |
Pages: |
82-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fox JC |
Year: |
2015 |
Journal: |
Cytokine |
Title: |
Structural and agonist properties of XCL2, the other member of the C-chemokine subfamily. |
Volume: |
71 |
Issue: |
2 |
Pages: |
302-11 |
|
•
•
•
•
•
|
Publication |
First Author: |
Geyer H |
Year: |
2014 |
Journal: |
J Virol |
Title: |
Cytomegalovirus expresses the chemokine homologue vXCL1 capable of attracting XCR1+ CD4- dendritic cells. |
Volume: |
88 |
Issue: |
1 |
Pages: |
292-302 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Chemokines (chemotactic cytokines) are a family of chemoattractant molecules. They attract leukocytes to areas of inflammation and lesions, and play a key role in leukocyte activation. Originally defined as host defense proteins, chemokines are now known to play a much broader biological role []. They have a wide range of effects in many different cell types beyond the immune system, including, for example, various cells of the central nervous system [], and endothelial cells, where they may act as either angiogenic or angiostatic factors [].The chemokine family is divided into four classes based on the number and spacing of their conserved cysteines: 2 Cys residues may be adjacent (the CC family); separated by an intervening residue (the CXC family); have only one of the first two Cys residues (C chemokines); or contain both cysteines, separated by three intervening residues (CX3C chemokines).Chemokines exert their effects by binding to rhodopsin-like G protein-coupled receptors on the surface of cells. Following interaction with their specific chemokine ligands, chemokine receptors trigger a flux in intracellular calcium ions, which cause a cellular response, including the onset of chemotaxis. There are over fifty distinct chemokines and least 18 human chemokine receptors []. Although the receptors bind only a single class of chemokines, they often bind several members of the same class with high affinity. Chemokine receptors are preferentially expressed on important functional subsets of dendritic cells, monocytes and lymphocytes, including Langerhans cells and T helpercells [, ]. Chemokines and their receptors can also be subclassified into homeostatic leukocyte homing molecules (CXCR4, CXCR5, CCR7, CCR9) versus inflammatory/inducible molecules (CXCR1, CXCR2, CXCR3, CCR1-6, CX3CR1).The C chemokine subfamily is composed of two members, XC chemokine ligand 1 (XCL1), also known as lymphotactin or SCM-1 alpha, and XC chemokine ligand 2 (XCL2), also known as SCM-1 beta []. The cognate receptor for these chemokines is XCR1 [].XCL1 is an inflammatory chemokine that produced by activated CD8+ T cells and natural killer cells. It is involved in the mediation of interactions between antigen-presenting dendritic cells and T-cells, and induction of CD8+ effector T-cell responses [, ]. It is also involved in the formation of self-tolerance mechanisms through the development of T regulatory cells within the thymus []. Less is known about its closely related paralogue XCL2, although the in vitro functional profiles are virtually identical []. Human XCL2 and XCL1 amino acid sequences differ at only two positions near the N terminus [].Viral XCL1 (vXCL1) exclusively binds to CD4(-) rat dendritic cells (DC), a subset of DC that express the corresponding chemokine receptor XCR1, a strategy to subvert cytotoxic immune responses []. |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
114
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
322
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
338
 |
Fragment?: |
false |
|
•
•
•
•
•
|